Brain health, observed over time.
Six inflammatory biomarkers, measured from a blood sample you collect at home and read as one composite you can follow quarter over quarter. Access opens in stages.
A reading that changes is a reading you can follow.
The six analytes in this panel are inflammatory signals. Published work describes them rising and falling together as a network rather than drifting independently, which is the reason a second reading tells you something a first one cannot.
That is why SageSignal is built around repeat testing, and why it reports a trend alongside each individual value.
What any particular change means for an individual is not established. Nothing here is medical advice.
Six markers of inflammatory signalling.
Each of the six is a clinically recognized analyte studied in relation to cerebrovascular health. Together they form a composite reading you can follow across quarters rather than a single point in time.
The six markers are biologically connected.
Published work describes these six analytes as an interconnected inflammatory network centred on IL-18, rather than six independent readings. That is the reason SageSignal reports a composite alongside the individual values.
The composite is a normalized average across the panel, so no single analyte drives the reading on its own.
See the published researchThree steps, no clinic visit.
Collect at home
The kit uses a Tasso+ device that attaches to the upper arm. No finger pricks, and no phlebotomist.
Laboratory analysis
Your sample is analyzed in a CLIA-certified laboratory. The six-marker panel runs as a single multiplex assay.
Read the trend
Your report shows each marker against its reference range and a composite reading you can follow quarter over quarter.
You see the panel, and you see the trend.
Every marker is reported with its value, its unit, and where it sits relative to a reference population. The composite sits above them. Test again and the report keeps the history.
Illustrative example, not a real reading. Values shown are for layout only.
The science is published, and it lives on its own page.
The biomarker panel draws on peer-reviewed work published by independent investigators in PLOS ONE and Frontiers in Neurology. We link to the journals rather than summarising them here.
That research concerns the biomarkers and the underlying cerebrovascular science. It is not a claim about the performance of any Sage Cerebro product.
Research and publicationsBe among the first.
Name and email is all we ask. We will write when your place comes up, and we never ask health questions.
We use your details only to contact you about SageSignal availability. No health information is collected, and we do not sell or share personal information. See the privacy policy.
You are on the list.
We will write to you at the address you gave when your place comes up. Nothing else.